Decision Diagnostics Corp (DECN)

[Raffis]

DECN CREATED THE ONLY MULTI-VIRAL DETECTION TEST WITH A PATENTED “TBG SYSTEM” THAT ELIMINATES THE NEED TO LYSE BLOOD HEMATOCRIT FOR VIRAL ISOLATION AND DETECTION. OUR TEST DOES NOT REQUIRE ANY LYSIS BUFFER, AND COMPLETELY ELIMINATES HEMATOCRIT CROSS REACTIVITY WITH OUR PATENTED “TBG-ADJUSTMENT” FEATURE. THE GENVIRO SWIFT INCORPORATES THE “TBG”TECHNOLOGY THAT ELIMINATES ANY HEMATOCRIT INTERFERENCE. OUR EXCLUSIVE GENVIRO SWIFT PROVIDES HIGH THROUGHPUT, DIAGNOSTIC, LAB QUALITY RESULTS THAT ARE COMPARABLE TO EXISTING, SLOWER AND MORE COSTLY VIROLOGICAL TESTS. OUR VIROLOGICAL TEST PROVIDES RESULTS IN 10.5 SECONDS. OUR TEST PRODUCES THE FASTEST VIRUS DETECTION RESULTS IN THE WORLD WITH USFDA REQUIRED ACCURACY AND SENSITIVITY REQUIREMENTS.

IN ADDITION TO THE EMBEDDED TBG-TECHNOLOGY, DECN ALSO COMBINED THE MULTI-FUNCTIONALITY OF DETECTING VIRUSES THROUGH SALIVA, OR BLOOD IN THE SAME TEST METER WITH THE SAME MULTI-FUNCTIONAL, STATE OF THE ART, PATENTED TEST STRIPS. DECN IS THE ONLY COMPANY IN THE WORLD THAT OFFERS THIS MULTI-FUNCTIONAL, VIRUS DETECTING TECHNOLOGY THAT SATISFIES THE USFDA REQUIREMENTS FOR IN VITRO VIRUS DETECTION PROTOCOLS, WITH HIGH ACCURACY LEVELS AND USER FRIENDLY EFFICIENCY.

THE COMBINED FEATURES OF THE GENVIRO SWIFT RESULT IN A REVOLUTIONARY MULTI-FUNCTIONAL VIRUS TESTING METER THAT PROVIDES THE FASTEST, GROUND BREAKING RESULTS THAT IS EXCLUSIVELY PROVIDED BY DECN’s PATENTED DESIGN.